Attention-deficit hyperactivity disorder

British Journal of General Practice

Volumn 53, Issue 488, 2003, Pages 225-230

  Thapar, Ajay K ^a   Thapar, Anita ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; Diagnosis; Management

Indexed keywords

ANALGESIC AGENT; CENTRAL STIMULANT AGENT; DESMOPRESSIN; EQUASYM; METHYLPHENIDATE; NEUROLEPTIC AGENT; PLACEBO;

ANAMNESIS; ATTENTION DEFICIT DISORDER; CHILD HEALTH CARE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG MECHANISM; ENVIRONMENTAL FACTOR; HEALTH SERVICE; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; NOCTURNAL ENURESIS; PREVALENCE; PRIMARY MEDICAL CARE; PROGNOSIS; REVIEW; SCREENING TEST; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; UNITED KINGDOM;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FAMILY PRACTICE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; PROGNOSIS; REFERRAL AND CONSULTATION;

EID: 0037337371     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. American Psychiatric Press. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: The Press, 1994.
2. World Health Organization. International Classification of Diseases (ICD-10). Geneva: WHO, 1993.
3. Taylor E, Hemsley R. Treating hyperkinetic disorders in childhood. BMJ 1995; 310: 1617-1618.
4. Taylor E, Sandberg S, Thorley G, Giles S. The Epidemiology of Childhood Hyperactivity. [Maudsley Monograph.] London: Oxford University Press, 1991.
5. Meltzer H, Gatward R, Goodman R, Ford T. Mental Health of Children and Adolescents in Great Britain. London: The Stationery Office, 2000.
6. Barkley RA. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd Edition. New York: Guilford Press, 1998.
7. Guevara J, Lozano P, Wickizer T, et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 2001; 108(1):71-78.
8. Mannuzza S, Klein RG, Bessler A, et al. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998; 155: 493-498.
9. Farrington DP, Loeber R, Van Kammen WB. Long-term criminal outcomes of hyperactivity-impulsivity, attention deficit and conduct problems in childhood. In: Robins LN, Rutter M (eds). Straight and Devious Pathways from Childhood to Adulthood. Cambridge: Cambridge University Press, 1990; 62-81.
10. Still GF. Some abnormal psychical conditions in children. Lancet 1902; 1: 1008-1012. Quoted in: Barkley RA. Attention deficit hyperactivity disorder: A handbook for diagnosis and treatment. 2nd edition. New York: Guilford Press, 1998.
11. Summerfield D. The invention of post-traumatic stress disorder and the social usefulness of a psychiatric category. BMJ 2001; 322: 95-98.
12. Double D. The limits of psychiatry. BMJ 2002; 324: 900-904.
13. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56(12): 1073-1086.
14. Herrerias CT, Perrin JM, Stein MT. The child with ADHD: Using the AAP Clinical Practice Guideline. American Academy of Pediatrics. Am Fam Physician 2001; 63(9): 1803-1810.
15. National Institute for Clinical Excellence. Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood. [Technology Appraisal Guidance No. 13] http://www.nice.org.uk (accessed 23 January 2003)
16. Scottish Intercollegiate Guidelines Network. Attention deficit and hyperkinetic disorders in children and young people. [SIGN Publication No. 52.] 2001. http://www.sign.ac.uk (accessed 23 January 2003)
17. Walsall shared care protocol. URL: http://www.ukmicentral.nhs.uk/guide/pdf/methylphenidate.pdf (accessed 23 January 2003)
18. North Derbyshire Priorities and Clinical Effectiveness (PACE) Forum. Shared care agreement for methylphenidate. URL: http://www.ukmicentral.nhs.uk/guide/sharedcare/methylphenidate.pdf (accessed 23 January 2003)
19. Sayal K, Taylor E, Beecham J, Byrne P. Pathways to care in children at risk of attention deficit hyperactivity disorder. Br J Psychiatry 2002; 181(1): 43-48.
20. Hill P. Attention deficit hyperactivity disorder. Arch Dis Child 1998; 79: 381-384.
21. Taylor E, Sergeant J, Doepfner M, et al. Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry. Eur J Child and Adolesc Psychiatry 1998; 7: 184-200.
22. Williams C, Wright B, Partridge I. Attention deficit hyperactivity disorder - A review. Br J Gen Pract 1999; 49: 563-571.
23. Conners CK, Sitarenios G, Parker JD, Epstein JN. Revision and restandardization of the Conners' Teacher Rating Scale (CTRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998; 26(4): 279-291.
24. Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners' Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998; 26(4): 257-268.
25. Hill P, Taylor E. An auditable protocol for treating attention deficit/hyperactivity disorder. Arch Dis Child 2001; 84(5): 404-409.
26. Lahey BB, Applegate B, McBurnett K, et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 1994; 151(11): 1673-1685.
27. Costello EJ, Angold A, Burns BJ, et al. The Great Smoky Mountains Study of Youth. Functional impairment and serious emotional disturbance. Arch Gen Psychiatry 1996; 53(12): 1137-1143.
28. Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: A community perspective. J Am Acad Child Adolesc Psychiatry 2000; 39(8): 975-984.
29. Jensen PS, Kettle L, Roper MT, et al. Are stimulants over-prescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry 1999 38(7): 797-804.
30. Ball C. Attention deficit hyperactivity disorder (ADHD) and the use of methylphenidate: A survey of the views of general practitioners. Psychiatr Bull 2001; 25: 301-304.
31. Sloan D. Who is responsible for child mental health? BMJ 1997; 315: 311.
32. Marshall E. Epidemiology. Duke study faults overuse of stimulants for children. Science 2000 4 August; 289(5480): 721.
33. Thapar A. Attention deficit hyperactivity disorder: New genetic findings, new directions. In: Plomin R, DeFries J, Craig I, McGuffin P. Behavioural Genetics in the Postgenomic Era. Washington DC: APA Books, 2002.
34. Rutter M, Giller H, Hagell A. Antisocial Behaviour by Young People. Cambridge: Cambridge University Press, 1998.
35. Law MR, Wald NJ. Risk factor thresholds: Their existence under scrutiny. BMJ 2002; 324: 1570-1576.
36. Overmeyer S, Taylor E. Neuroimaging in hyperkinetic children and adults: An overview. Pediatr Rehabil 2000; 4(2): 57-70.
37. Tannock R. Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological and genetic research. J Child Psychol Psychiatry 1998; 39: 65-69.
38. Castellanos FX, Lee PP, Sharp W, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288(14): 1740-1748.
39. Volkow ND, Wang G, Fowler JS, et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. J Neurosci 2001; 21(2): RC121.
40. Anderson JC. Is childhood hyperactivity the product of Western culture? Lancet 1996; 348(9020): 73-74.
41. Swanson JM, Lerner M, Williams L. More frequent diagnosis of attention deficit-hyperactivity disorder. N Engl J Med 1995; 333(14): 944.
42. Rutter M, Pickles A, Murray R, Eaves L. Testing hypotheses on specific environmental causal effects on behavior. Psychol Bull 2001; 127(3): 291-324.
43. Barkley RA, Fisher M, Edelbrock C, Smallish L. The adolescent outcome of hyperactive children diagnosed by research criteria III: Mother-child interactions, family conflicts and maternal psychopathology. J Child Psychol Psychiatry 1991 32(2): 233-255.
44. Barkley RA, Karlsson J, Pollard S, Murphy JV. Developmental changes in the mother-child interactions of hyperactive boys: Effects of two dose levels of Ritalin. J Child Psychol Psychiatry 1985; 26(5): 705-715.
45. Egger J, Carter CM, Graham PJ, et al. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet 1985; 1(8428): 540-545.
46. Spencer T, Biderman J, Wilens TE, Faraone SV. Adults with attention deficit/hyperactivity disorder: A controversial diagnosis. J Clin Psychiatry 1998; 59(Suppl 7): 59-68.
47. Thapar A, Thapar A. Is primary care ready to take on attention deficit hyperactivity disorder? BMC Fam Pract 2002; 3(1): 7.